Massachusetts General Hospital ACTG CRS (101) — Boston, Massachusetts

Massachusetts General Hospital ACTG CRS (101) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital ACTG CRS (101) has participated in 16 clinical trials.

Therapeutic areas: HIV-1 Infection, HIV Infections, Hepatitis C Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital ACTG CRS (101)?

Massachusetts General Hospital ACTG CRS (101) has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital ACTG CRS (101) conducted?

Massachusetts General Hospital ACTG CRS (101) has 16 clinical trials on record. Their work covers HIV-1 Infection, HIV Infections, Hepatitis C Infection.

Is Massachusetts General Hospital ACTG CRS (101) accredited by Crixeo Health?

Massachusetts General Hospital ACTG CRS (101) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital ACTG CRS (101)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.